(PDF) Treatment of Open-Angle Glaucoma and Ocular

Treatment of Open-Angle Glaucoma and Ocular Hypertension With Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: The VISIONARY Study

Advances in Therapy - United States

doi 10.1007/s12325-020-01239-8

Full Text

Open PDF

Abstract

Available in full text

Date

February 18, 2020

Authors

Publisher

Springer Science and Business Media LLC

Related search

Preservative-Free Tafluprost 0.0015% in the Treatment of Patients With Glaucoma and Ocular Hypertension

English

24-Hour Efficacy and Ocular Surface Health With Preservative-Free Tafluprost Alone and in Conjunction With Preservative-Free Dorzolamide/Timolol Fixed Combination in Open-Angle Glaucoma Patients Insufficiently Controlled With Preserved Latanoprost Monotherapy

English

Comparative Effectiveness of Bimatoprost 0.03%/Timolol 0.5% Preservative-Free Fixed Combination for the Treatment of Open-Angle Glaucoma and OHT; Interpreting Results From a Large Treatment Network

English

Preliminary Results Following the Use of a Fixed Combination of Timolol–brimonidine in Patients With Ocular Hypertension and Primary Open-Angle Glaucoma

Clinical Ophthalmology

Ophthalmology

2009

English

Safety and Tolerability of Tafluprost in Treatment of Elevated Intraocular Pressure in Open-Angle Glaucoma and Ocular Hypertension

Clinical Ophthalmology

Ophthalmology

2010

English

Brinzolamide/Brimonidine Fixed-Dose Combination Bid as an Adjunct to a Prostaglandin Analog for Open-Angle Glaucoma/Ocular Hypertension

European Journal of Ophthalmology

Medicine

Ophthalmology

2019

English

A Monocular Trial of Fixed Combination of Dorzolamide-Timolol for Primary Open-Angle Glaucoma

Journal of the Korean Glaucoma Society

2019

English

Clinical Effectiveness of Brinzolamide 1%–brimonidine 0.2% Fixed Combination for Primary Open-Angle Glaucoma and Ocular Hypertension

Clinical Ophthalmology

Ophthalmology

2015

English

Randomized, Controlled, Phase 3 Trials of Carteolol/Latanoprost Fixed Combination in Primary Open-Angle Glaucoma or Ocular Hypertension

American Journal of Ophthalmology

Ophthalmology

2016

English

Amanote Research

Treatment of Open-Angle Glaucoma and Ocular Hypertension With Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: The VISIONARY Study

Advances in Therapy - United States

doi 10.1007/s12325-020-01239-8

Full Text

Abstract

Categories

Date

Authors

Publisher

Related search

Preservative-Free Tafluprost 0.0015% in the Treatment of Patients With Glaucoma and Ocular Hypertension

24-Hour Efficacy and Ocular Surface Health With Preservative-Free Tafluprost Alone and in Conjunction With Preservative-Free Dorzolamide/Timolol Fixed Combination in Open-Angle Glaucoma Patients Insufficiently Controlled With Preserved Latanoprost Monotherapy

Comparative Effectiveness of Bimatoprost 0.03%/Timolol 0.5% Preservative-Free Fixed Combination for the Treatment of Open-Angle Glaucoma and OHT; Interpreting Results From a Large Treatment Network

Preliminary Results Following the Use of a Fixed Combination of Timolol–brimonidine in Patients With Ocular Hypertension and Primary Open-Angle Glaucoma

Safety and Tolerability of Tafluprost in Treatment of Elevated Intraocular Pressure in Open-Angle Glaucoma and Ocular Hypertension

Brinzolamide/Brimonidine Fixed-Dose Combination Bid as an Adjunct to a Prostaglandin Analog for Open-Angle Glaucoma/Ocular Hypertension

A Monocular Trial of Fixed Combination of Dorzolamide-Timolol for Primary Open-Angle Glaucoma

Clinical Effectiveness of Brinzolamide 1%–brimonidine 0.2% Fixed Combination for Primary Open-Angle Glaucoma and Ocular Hypertension

Randomized, Controlled, Phase 3 Trials of Carteolol/Latanoprost Fixed Combination in Primary Open-Angle Glaucoma or Ocular Hypertension

Amanote Research

Treatment of Open-Angle Glaucoma and Ocular Hypertension With Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: The VISIONARY Study

Advances in Therapy - United States

doi 10.1007/s12325-020-01239-8

Full Text

Abstract

Categories

Date

Authors

Publisher

Related search

Preservative-Free Tafluprost 0.0015% in the Treatment of Patients With Glaucoma and Ocular Hypertension

24-Hour Efficacy and Ocular Surface Health With Preservative-Free Tafluprost Alone and in Conjunction With Preservative-Free Dorzolamide/Timolol Fixed Combination in Open-Angle Glaucoma Patients Insufficiently Controlled With Preserved Latanoprost Monotherapy

Comparative Effectiveness of Bimatoprost 0.03%/Timolol 0.5% Preservative-Free Fixed Combination for the Treatment of Open-Angle Glaucoma and OHT; Interpreting Results From a Large Treatment Network

Preliminary Results Following the Use of a Fixed Combination of Timolol&ndash;brimonidine in Patients With Ocular Hypertension and Primary Open-Angle Glaucoma

Safety and Tolerability of Tafluprost in Treatment of Elevated Intraocular Pressure in Open-Angle Glaucoma and Ocular Hypertension

Brinzolamide/Brimonidine Fixed-Dose Combination Bid as an Adjunct to a Prostaglandin Analog for Open-Angle Glaucoma/Ocular Hypertension

A Monocular Trial of Fixed Combination of Dorzolamide-Timolol for Primary Open-Angle Glaucoma

Clinical Effectiveness of Brinzolamide 1%&ndash;brimonidine 0.2% Fixed Combination for Primary Open-Angle Glaucoma and Ocular Hypertension

Randomized, Controlled, Phase 3 Trials of Carteolol/Latanoprost Fixed Combination in Primary Open-Angle Glaucoma or Ocular Hypertension

Preliminary Results Following the Use of a Fixed Combination of Timolol–brimonidine in Patients With Ocular Hypertension and Primary Open-Angle Glaucoma

Clinical Effectiveness of Brinzolamide 1%–brimonidine 0.2% Fixed Combination for Primary Open-Angle Glaucoma and Ocular Hypertension